282
Participants
Start Date
September 27, 2018
Primary Completion Date
January 16, 2026
Study Completion Date
January 16, 2026
mavacamten
mavacamten capsules
Local Institution - 0001, Brussels
Local Institution - 0012, Frederiksberg
Local Institution - 0003, Edegem
Local Institution - 0013, Odense
Local Institution - 0011, Aarhus
Local Institution - 0002, Aalst
Local Institution - 0060, New York
Local Institution - 0056, New York
Local Institution - 0023, Safed
Local Institution - 0038, A Coruña
Local Institution - 0064, Pittsburgh
Local Institution - 0068, Bethlehem
Local Institution - 0046, Philadelphia
Local Institution - 0053, Charlottesville
Local Institution - 0059, Richmond
Local Institution - 0047, Durham
Local Institution - 0040, Madrid
Local Institution - 0071, Charlotte
Local Institution - 0039, Majadahonda
Local Institution - 0037, El Palmar
Local Institution - 0015, Toulouse
Local Institution - 0067, Jacksonville
Local Institution - 0019, Göttingen
Local Institution - 0073, Memphis
Local Institution - 0041, Seville
Local Institution - 0014, Nantes
Local Institution - 0052, Cincinnati
Local Institution - 0070, Indianapolis
Local Institution - 0051, Ann Arbor
Local Institution - 0074, Grand Rapids
Local Institution - 0028, Florence
Local Institution - 0049, Iowa City
Local Institution - 0022, Ramat Gan
Local Institution - 0050, Chicago
Local Institution - 0020, Bad Nauheim
Local Institution - 0048, St Louis
Local Institution - 0021, Heidelberg
Local Institution - 0017, Paris
Local Institution - 0016, Paris
Local Institution - 0061, Dallas
Local Institution - 0025, Rehovot
Local Institution - 0055, Houston
Local Institution - 0057, Houston
Local Institution - 0062, Salt Lake City
Local Institution - 0045, Scottsdale
Local Institution - 0058, Los Angeles
Local Institution - 0066, San Francisco
Local Institution - 0063, Stanford
Local Institution - 0044, Portland
Local Institution - 0065, Seattle
Local Institution - 0024, Petah Tikva
Local Institution - 0026, Tel Aviv
Local Institution - 0027, Jerusalem
Local Institution - 0043, New Haven
Local Institution - 0054, Boston
Local Institution - 0072, Murray
Local Institution - 0010, Prague
Local Institution - 0009, Prague
Local Institution - 0018, Dresden
Local Institution - 0029, Maastricht
Local Institution - 0030, Rotterdam
Local Institution - 0033, Katowice
Local Institution - 0034, Krakow
Local Institution - 0031, Poznan
Local Institution - 0032, Warsaw
Local Institution - 0036, Almada
Local Institution - 0035, Lisbon
Local Institution - 0042, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY